“Some countries have stocks of the first generation vaccine... We do not know the exact number of doses available in the world, so we encourage countries to contact WHO and tell us what their stocks are... Have they checked the effectiveness of these vaccines,” leads her words Politico.
Moderna previously said it was conducting preclinical studies of possible monkeypox vaccines.
Chief researcher at the Institute of Molecular Biology of the Russian Academy of Sciences, Corresponding Member of the Russian Academy of Sciences Pyotr Chumakov, in an interview with RT, noted that a vaccine created against smallpox can provide protection against the monkeypox virus and stocks of such drugs still exist in a number of countries.
On the eve of the British Health Agency reported that the number of cases of infection with monkeypox in the UK has exceeded 100.